| Name |
Research Interests |
| Adair, Gerald M. Ph.D. | DNA repair and mutagenesis, homologous recombination, gene targeting |
| Aldaz, C. Marcelo M.D. | Breast cancer genetics, carcinogenesis, mammary tumor models, breast cancer biomarkers, tamoxifen resistance |
| Angel, Joe M. Ph.D. | Disease modifier genes, complex trait genetics, tumor genetics, carcinogenesis |
| Bedford, Mark T. Ph.D. | Proteomics, arginine methylation, gene targeting, protein arrays |
| Benavides, Fernando D.V.M., Ph.D., DACLAM | Mouse genetics, cancer susceptibility genes, mouse models with epidermal and hair follicle defects |
| Butler, Andrew P. Ph.D. | Transcriptional regulation, signal transduction, cell cycle, skin cancer |
| Coghlan, Lezlee G. D.V.M., M.S. | Mouse models of cancer, optical imaging, facility management, rodent diseases, parasitology |
| Conti, Claudio J. D.V.M., Ph.D. | Genes, keratinocytes, prostate |
| DiGiovanni, John Ph.D. | Epithelial carcinogenesis, oncogenes, growth factors, transgenic models, cancer prevention |
| Fischer, Susan M. Ph.D. | Skin carcinogenesis, pancreatic cancer, inflammation, arachidonic acid metabolism, peroxisome proliferator-activated receptors |
| Fuchs-Young, Robin Ph.D. | Breast cancer, hormone action, crosstalk, growth hormones, p53, hormonal carcinogenesis, obesity |
| Gimenez-Conti, Irma B. D.D.S., Ph.D. | Modulation of tumor progression, chemopreventive agents, intermediate biomarkers |
| Hursting, Stephen D. Ph.D., M.P.H. | Diet-gene interactions relevant to cancer prevention, particularly the molecular and hormonal mechanisms underlying energy balance-cancer associations |
| Johanning, Gary L. Ph.D. | Vitamins and chemotherapy, cisplatin resistance genes, vitamins and cancer prevention, obesity and cancer, acyl coenzyme A binding protein, folic acid and cell-mediated immunity |
| Johnson, David G. Ph.D. | Cancer genetics; DNA damage response; apoptosis; cell cycle |
| Kiguchi, Kaoru M.D., Ph.D. | EGF receptor, ErbB family, tumor promotion, multistage skin carcinogenesis, biliary tract cancers |
| Kusewitt, Donna, D.V.M, Ph.D. | Skin carcinogenesis, epithelial-mesenchymal transformation, genetically engineered mice, comparative pathology |
| Li, Donghui Ph.D. | DNA damage, genetic susceptibility, carcinogenesis, molecular epidemiology |
| MacLeod, Michael C. Ph.D. | Chemical carcinogenesis, breast cancer, DNA damage response, mustard gas |
| McArthur, Mark D.V.M., D.A.C.V.P. | Pathology of transgenic and gene targeted mice, pathology of rodent models of carcinogenesis, and the role of acyl-CoA binding protein in carcinogenesis |
| Mitchell, David L. Ph.D. | UV photochemistry, photobiology and photocarcinogenesis, DNA repair, UV environmental photobiology |
| Nairn, Rodney S. Ph.D. | DNA repair, genetic recombination, sunlight carcinogenesis |
| Richie, Ellen R. Ph.D. | Thymus organogenesis, T cell development, thymic lymphoma |
| Rundhaug, Joyce Ph.D. | Mouse skin carcinogenesis, cyclooxygenases, prostaglandins, malignant progression, matrix metalloproteinases |
| Shen, Jianjun Ph.D. | Proteomics, 2-D gel electrophoresis, biological markers, pancreatic cancer |
| Shen, Xuetong Ph.D. | Chromatin responses to DNA damage, nuclear actin and related proteins |
| Tang, Dean G. Ph.D. | Cancer stem cells, apoptosis, prostate cancer |
| Vasquez, Karen M. Ph.D. | DNA damage and repair, genomic instability, gene targeting, DNA structure, cancer therapeutics |
| Walker, Cheryl L. Ph.D. | Cell signaling pathways, endocrine disruptors, cellular responses to oxidative stress and DNA damage, genitourinary and female reproductive tract cancers, polycystic kidney disease (PKD), Tuberous Sclerosis Complex 2 (TSC2) tumor suppressor gene |
| Wong, Paul K.Y. Ph.D. | Retrovirus and ATM-mediated neuroimmunodegeneration, oxidative stress, signal transduction, therapeutic intervention |
| Wood, Richard D. Ph.D. | DNA repair mechanisms and damage responses, DNA polymerases, DNA damage tolerance, genetic dependence of mutagenesis and carcinogenesis |
| Yan, Mingshan M.D., Ph.D. | Retrovirus-induced neurodegeneration and its prevention with antioxidants, Ataxia Telangiectasia Mutated (ATM) in thymocyte development and lymphoid tumorigenesis |